Sylvain Doré, PhD, has been awarded a new research grant from the National Institute of Neurological Disorders and Stroke (NINDS) within the National Institutes of Health (NIH).
The grant is entitled “Potential stroke therapeutic efficacy of FumET-CORM through the Nrf2 pathway”. This $419,375 grant will fund Dr. Doré’s research on this project for two years.
The R21 Exploratory/Developmental Research Grant Award is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development.
Congratulations to Dr. Doré and the Doré Lab!